BORTEZOMIB/DEXAMETHASONE (BD), FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION AND MAINTENANCE BORTEZOMIB/DEXAMETHASONE FOR THE INITIAL TREATMENT OF MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE (MIDD) ASSOCIATED WITH MULTIPLE MYELOMA AND AL AMYLOIDOSIS: